Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$28,371,826
-$4,681,563 QoQ
Shares Held
1,178,232
+0.1% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#232
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANCO BILBAO VIZCAYA ARGENTARIA, S.A. holds $411,851,999 across 11 Drug Manufacturers - General names. PFE ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
91,229 | $109,422,808 | |
| 2 | ABBV |
AbbVie Inc.
|
319,602 | $80,424,647 | |
| 3 | MRK |
Merck & Co., Inc.
|
369,659 | $47,501,181 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
363,083 | $45,871,906 | |
| 5 | AMGN |
Amgen Inc
|
94,325 | $34,156,969 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
507,605 | $29,248,200 | |
| 7 | PFE |
Pfizer Inc
This page
|
1,178,232 | $28,371,826 | |
| 8 | JNJ |
Johnson & Johnson
|
50,162 | $12,739,643 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,371,826 | 1,178,232 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $33,053,389 | 1,177,115 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $29,963,415 | 1,203,350 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $45,043,849 | 1,767,812 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $42,112,976 | 1,737,334 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $43,339,990 | 1,710,339 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $33,262,146 | 1,253,756 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $27,431,270 | 947,867 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $26,999,161 | 964,945 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $35,776,215 | 1,289,233 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $36,296,963 | 1,260,749 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $36,629,398 | 1,104,293 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $28,770,985 | 784,378 | Shares | Defined | 2023-08-04 | |
| 2023-03-31 | $47,828,983 | 1,172,279 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $53,247,224 | 1,039,173 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $49,488,577 | 1,130,909 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $55,238,308 | 1,053,563 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $45,588,972 | 880,606 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $37,191,461 | 629,830 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $14,188,568 | 329,890 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $11,936,712 | 304,819 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $11,595,628 | 320,056 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $20,544,544 | 558,124 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $14,405,176 | 392,512 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $11,006,962 | 336,604 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $6,932,237 | 212,385 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||